Wren Laboratories

Molecular Diagnostics Laboratory leveraging mRNA and AI to create liquid biopsy tests that help oncologists better manage cancer. #NETest #NETestPPQ

[Wren Laboratories @WrenLabs]

NYSDOH has approved Wren Laboratories’ NETest® 2.0!
A major advance in precision care for neuroendocrine tumors — accurate diagnosis, real-time monitoring, and treatment-response prediction.
More: https://t.co/brB3TCIl5f

[Wren Laboratories @WrenLabs]

Wren Laboratories Announces Acquisition of Pure Diagnostic, Unifying Clinical Laboratory Operations Under the Wren Brand
Read more: Wren Laboratories Announces Acquisition of Pure Diagnostic, Unifying Clinical Laboratory Operations Under the Wren Brand | Newswise

[Wren Laboratories @WrenLabs]

Proud moment! Wren Laboratories achieved ISO 15189 accreditation in record time after auditors called our systems “super-human” and converted the gap audit straight to accreditation.
Quality. Precision. Excellence. #ISO15189 #Healthcare #Lab

[Wren Laboratories @WrenLabs]

Wren proudly supports Prostate Cancer Awareness Month. Learn more about PROSTest® at https://t.co/l2jTQxCVhN

[Wren Laboratories @WrenLabs]

🩸 Wren Labs, CLIA/CAP/NYSDOH certified, revolutionizes prostate cancer care with PROSTest!
Our AI-enhanced liquid biopsy offers:
✅ 96% sensitivity, 99.3% specificity—outperforms PSA
✅ 94% sensitivity for MRD/recurrence (vs. 79% for PET)

https://t.co/Ipaxi59rbB

[Wren Laboratories @WrenLabs]

🩸Wren Labs, CLIA/CAP/NYSDOH certified, transforms NET diagnostics with NETest 2.0!
Our AI-enhanced liquid biopsy offers:
✅ >95% sensitivity for NET detection
✅ >90% accuracy for disease progression
✅ PPQ score predicts PRRT response (98% PPV, 93% NPV)

https://t.co/x7fYc2Dy29

[Wren Laboratories @WrenLabs]

#fbf to our time at #WorldCDx in Boston! We shared how we are unlocking a deeper cancer understanding through Molecular Diagnostics > https://t.co/G7p8NGeA2L

#BeatCancer #mRNA #liquidbiopsy #wrenlabs #tradeshow #prostatecancerawarenessmonth #seaport #boston

[Wren Laboratories @WrenLabs]

Let's meet this week at #WorldCDx in Boston! Come visit us at Booth #37.
Learn how we are unlocking a deeper cancer understanding through Molecular Diagnostics > https://t.co/ju5sjPwKjG

#BeatCancer #mRNA #liquidbiopsy #wrenlabs #prostatecancerawarenessmonth #seaport #boston

[Wren Laboratories @WrenLabs]

🚲 We are proud to be a sponsor for this years "Closer to Free" 2024 Ride happening at the Yale-bowl this Saturday. 100% of money raised by riders directly impacts these important programs.

#cancersucks #closertofree #yalebowl #wrenlab #charity #dogoodfeelgood

[Wren Laboratories @WrenLabs]

#tbt to our booth at #NextGenerationDx Summit in DC…It was so great to meet everyone. For those we didn’t get to meet with let’s talk. Connect with us here > https://t.co/WlclltMito

#prostest #cancer #earlydetection #nextgendx #NGDx #cambridgehealthtech #mRNA

[Wren Laboratories @WrenLabs]

✈️ Heading to #WorldCDx in Boston next week? Stop by Booth #37. Learn how we are unlocking a deeper cancer understanding through Molecular Diagnostics > https://t.co/lBi5tbbJfn

#mRNA #liquidbiopsy #WorldCDx2024 #wrenLaboratory #biopharma #LDT #cancerbiomarker #prostatecancer

[Wren Laboratories @WrenLabs]

Thanks for joining our quizz on liquid biopsies for NETs last week! The odd one out is Caspases. They’re key in apoptosis, not used as biomarkers for NETs. CTCs, cfDNA, and Exosomes are crucial for detecting NETs. Stay tuned for more! #WrenLabs #LiquidBiopsy #NETs

[Wren Laboratories @WrenLabs]

Meet the minds behind our liquid biopsy tech! Since 2014, we've revolutionized cancer diagnostics. We enhance minimal residual disease detection, predict therapy responses, and improve patient outcomes. #CancerResearch #LiquidBiopsy #TeamAppreciation

[Wren Laboratories @WrenLabs]

Liquid biopsies can detect neuroendocrine tumors (NETs) through various biomarkers, but can you spot the odd one out? Find out why next Monday! #WrenLabs #LiquidBiopsy #NETS

[Wren Laboratories @WrenLabs]

Advancing cancer diagnostics with liquid biopsy! Non-invasive tech detects & monitors cancer through blood tests. Key points:
Non-invasive, Early detection, Comprehensive insights, Clinical use in cancers, FDA-approved
#LiquidBiopsy #CancerDiagnostics #MedicalInnovation

[Wren Laboratories @WrenLabs]

🌟 Wren Laboratories announces Dr. Abdel Halim as our new CEO & CSO, leading our mission to enhance precision medicine and expand into biopharma services. #Innovation #Biotech #Leadership

[Wren Laboratories @WrenLabs]

🚀 Big news from Wren Laboratories! We’re excited to unveil our dynamic executive leadership team and our 2024 commercial strategy overhaul. Get ready for innovation and growth in diagnostic solutions. #Healthcare #Diagnostics #Leadership

[Wren Laboratories @WrenLabs]

It's NET Cancer Day! Our latest blog post details some of the symptoms for various forms of Neuroendocrine Cancer - please share. You could save a life. https://t.co/dmDYeyBAPL

[Wren Laboratories @WrenLabs]

A 2020 survey by the International Neuroendocrine Cancer Alliance revealed that the average time to a diagnosis for a North American NET patient is 6.44 years. When finally diagnosed, >50% presented with neuroendocrine cancer that had metastasized. https://t.co/JlBYgpnEs1